BUX · BioMark Diagnostics Inc. · Financials
Market Cap
47.92M CAD
Shares
106.48M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
154.22K
-5.5%
FY2025
Net Income
-1.93M
-35%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| CAD | 154.22K | 163.22K |
| CAD | -1.93M | -1.43M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.